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Tuberculosis (TB) is among the top infectious causes of morbidity and mortality worldwide
and is associated with frequent pulmonary damage despite microbiological cure. Patients
with treated TB may remain lifelong sufferers of disabling structural and functional seque-
lae of the disease, which subsequently impair quality of life.
Long-term follow-up studies have revealed that many patients with treated pulmonary
TB show signs of permanent impairment of their lung function. Impairment is variable
in pattern and severity, ranging from none to severe, and shows restrictive, obstructive,
or mixed patterns. Patients who presented with recurrent tuberculosis had a 2.8–3.0-fold
higher likelihood of developing abnormal lung function at the end of treatment than those
with a first episode of TB.
A variety of noninfectious pulmonary disorders are also common in post-TB patients. (1)
Parenchymal disorders that include thin-walled cavities (open negative syndrome), and
lung fibrosis with structural destruction and scar carcinoma. (2) Airway disorders that
include subglottic stenosis, chronic obstructive air flow obstruction, bronchiectasis, tra-
cheobronchial stenosis, anthracofibrosis, and broncholithiasis. (3) Vascular lesions such
as Rasmussen aneurysm. (4) Pleural lesions that range from pleural thickening to severe
fibrothorax. (5) General complications that include cor pulmonale, secondary amyloidosis,
and chronic respiratory failure. The prevalence of these abnormalities among patients
completing anti-TB treatment is alarmingly high. In fact, some studies have suggested
greater morbidity from the sequelae rather than from the disease itself. It is important
to be aware of the full spectrum of these disorders to facilitate early diagnosis and
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